European Pharmacopoeia looks to international experts to help harmonization
The European Pharmacopoeia Commission (Ph. Eur.) has decided to recruit international experts to ensure the compendium evolves with the globalisation of the pharma industry.
Archives for February 16, 2016
Biocon receives first generic approval in EU
Biocon, an Indian biopharmaceuticals company, has received European approvals for its Rosuvastatin Calcium, a generic equivalent of AstraZeneca’s Crestor tablets.
AstraZeneca: Eli Lilly discovery pact won't raise competitive concerns
AstraZeneca has no competitive concerns about teaming with Eli Lilly to identify chronic kidney disease (CKD) targets.
Generics consolidation continues: Mylan to acquire Meda for $9.9bn
The generic pharmaceuticals company, Mylan, has announced its offer to buy the Swedish specialty pharma company, Meda, in a deal valued at $9.9 bn.
Real-world data studies could 'revitalize' productivity, says analyst
Pharmaceutical companies can optimize market access by analyzing real-world trends in different treatment spaces, according to a new report.